Paranovus Entertainment Technology Ltd. (PAVS) AI Stock Analysis
PAVS AI stock analysis summary
AI ResearchParanovus Entertainment Technology Ltd. (PAVS) is a consumer defensive company focused on dietary supplements and e-commerce services. In FY2026, revenue increased to $14.6M from $71,542 in FY2025, though net income remained negative at -$12.7M. The stock trades at a market capitalization of $2.6M following a 1-year return of -100.0%.
- Market cap
- $2.6M
- Revenue (TTM)
- $14.6M
- P/E
- —
- 1Y return
- -100.0% S&P 500 16.8%
- Avg. target
- —
Bull case
- Revenue rebounded sharply in FY2026 to $14.6M, representing annual growth of 20310.9%.
- The balance sheet maintains $15.3M in cash and short-term investments against debt of $725,202, supporting net cash of $14.5M as of June 30, 2026.
- Gross margin turned positive at 16.5% in FY2026, recovering from -518.6% in FY2025.
Bear case
- The company continues to report annual losses, including net income of -$12.7M and an operating margin of -23.1% in FY2026.
- Free cash flow remained negative at -$1.4M in FY2026, extending multiple years of ongoing cash outflows.
- Long-term revenue trend remains pressured, evidenced by a 5-year revenue CAGR of -27.2% through FY2026.
What Paranovus Entertainment Technology does
Paranovus Entertainment Technology Ltd., headquartered in Nanping, the People's Republic of China, specializes in the research, development, manufacture, and global distribution of nutraceutical and dietary supplement products. Established in 2004 and previously known as Happiness Development Group Limited, its product portfolio includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng derivatives, herbal extracts, vitamins, and minerals marketed under the Happiness brand. In addition, the company operates the Happy Buy platform to deliver marketing and e-commerce agency services, offers internet information and advertising services, and manages the Taochejun automobile sales platform to facilitate vehicle procurement and financial services.
Growth and profitability
Paranovus has experienced significant revenue volatility, marked by a 5-year revenue CAGR of -27.2% from FY2021 to FY2026. Revenue fell from $89.5M in FY2022 to $23.3M in FY2023, $6.5M in FY2024, and $71,542 in FY2025, before growing 20310.9% to $14.6M in FY2026. Gross margin rebounded to 16.5% in FY2026 from -518.6% in FY2025, while operating margin improved from -3213.6% to -23.1%. Net income stood at -$12.7M in FY2026, representing a net margin of -87.2%. In the latest quarter ended June 30, 2026, quarterly revenue grew 70798.0% year-over-year, while trailing twelve months operating margin was -125.5%.
Balance sheet and cash flow
As of June 30, 2026, Paranovus held $15.3M in cash and short-term investments alongside total debt of $725,202, leaving a net cash position of $14.5M. The company reported a current ratio of 8.18 and a debt-to-equity ratio of 0.02, with shareholders' equity of $31.2M and total assets of $36.9M. In FY2026, operating cash flow was -$1.4M and free cash flow was -$1.4M, while the 5-year share count change stood at -100.0%.
Valuation and performance
With a market cap of $2.6M, Paranovus trades at an enterprise value of -$11.1M. Its price-to-sales multiple is 0.2x, which is lower than the 0.7x median of its US-listed Consumer Defensive peers. The stock's price-to-book ratio is 0.1x and its EV-to-revenue ratio is 0.3x. Over the past year, PAVS generated a return of -100.0%, trailing the S&P 500 return of 16.8%. Over a 5-year span, the stock returned -100.0% compared to 83.0% for the index, closing at $3.04 on October 16, 2026, down from a 52-week high of $144000.00.
What analysts expect
Paranovus has recorded 0 EPS beats over the last 4 quarters. The company's next earnings date is scheduled for November 13, 2026. Over the trailing twelve months, diluted earnings per share were -$8485.00, following an annual EPS of -$1.12 reported for FY2025.
Key risks and what to watch
- Persistent unprofitability is shown by a trailing twelve months operating margin of -125.5% and profit margin of -87.2%.
- Share price volatility has been extreme, declining to a last close of $3.04 compared to a 52-week high of $144000.00.
- Insiders hold 0.0% of shares, while institutional ownership stands at 13.0% and short interest accounts for 4.3% of the float.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this PAVS AI stock analysis
This page is an AI-written research summary of Paranovus Entertainment Technology Ltd. (PAVS). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: PAVS income statement, PAVS balance sheet, PAVS key metrics, PAVS chart. See the PAVS stock overview for the latest quote and news.
PAVS AI stock analysis FAQ
What products and platforms does Paranovus Entertainment Technology Ltd. operate?
Paranovus develops and distributes nutraceuticals and dietary supplements under the Happiness brand, including herbal extracts and vitamins. It also runs the Happy Buy e-commerce service platform and the Taochejun automotive sales platform.
What is the financial position of PAVS regarding cash and debt?
As of June 30, 2026, the company held $15.3M in cash and short-term investments and $725,202 in total debt, resulting in net cash of $14.5M.
Does PAVS pay a dividend?
Paranovus Entertainment Technology Ltd. does not pay a dividend.
When is the next earnings release for PAVS?
The company's next earnings date is scheduled for November 13, 2026.